Skip to content

Clinical trials

Phase 2 Neuralgia, Postherpetic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia, Postherpetic Phase: Phase 2 Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20062
20073
20087
20094
20104
20112
20122
20132
20141
20151
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated6
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
NeurogesX3
Allergan2
Winston Laboratories2
XenoPort, Inc.2
Aestus Therapeutics1
Bausch Health Americas, Inc.1
Bristol-Myers Squibb1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Durect1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia, Postherpetic33
Herpes Zoster14
Neuralgia13
Pain10
Agnosia2
Chickenpox2
Hyperalgesia2
Peripheral Nervous System Diseases2
Diabetes Mellitus1
Diabetic Neuropathies1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.